undamentalytics Newsletter
Sign in

Evolent Health, Inc. income statement

In fiscal 2025, Evolent Health, Inc. reported revenue of $1.88bn, down 26.6% on the year before, operating income of −$410m (a -21.9% margin) and net income of −$535m, or −$5.07 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Revenue2544356276879259081,3521,9642,5551,8762,097
Cost of revenue—————6581,0351,5032,1871,4761,735
Gross profit—————250317460367400362
Research and development111718201516—————
Selling, general and administrative161206235236210219269358263304292
Operating income−237−73−47−309−263−424−71−40−410−428
Interest expense0451528251654255769
Net interest income1——————————
Income before tax−238−76−54−330−331−30−62−202−63−535−502
Income tax−11−70−23−20−43−89−1−03
Net income−160−61−53−302−334−38−19−113−62−535−505
Diluted EPS−$3.55−$0.94−$0.68−$3.67−$3.94−$0.44−$0.20−$1.28−$0.81−$5.07−$4.49
Diluted shares (average)45m64m77m82m85m86m94m111m115m114m113m
EBITDA−220−40−3−248−20118715278−294−316

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: EVH vs RDNTEVH vs PRVAEVH vs HIMS

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Evolent Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 26, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Evolent Health, Inc.